Thrombin peptide, TP508, induces differential gene expression in fibroblasts through a nonproteolytic activation pathway

Experimental Cell Research

Volumn 247, Issue 2, 1999, Pages 422-431

  Sower, Laurie E ^a   Payne, Deborah A ^a   Meyers, Rebecca ^a   Carney, Darrell H ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Annexin V; Cell signaling; Nonproteolytic activation; Thrombin; Thrombin peptides; Thrombin receptors

Indexed keywords

LIPOCORTIN 5; THROMBIN; THROMBIN RECEPTOR;

ARTICLE; GENE INDUCTION; HUMAN; HUMAN CELL; LUNG FIBROBLAST; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 0033558796     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1998.4372     Document Type: Article

References (83)

1. Glenn K. C., Frost G. H., Bergmann J. S., Carney D. H. Synthetic peptides bind to high-affinity thrombin receptors and modulate thrombin mitogenesis. Peptide Res. 1:1988;65-73.
2. Carney D. H., Mann R., Redin W. R., Pernia S. D., Berry D., Heggers J. P., Hayward P. G., Robson M. C., Christie J., Annable C. Enhancement of incisional wound healing and neovascularization in normal rats by thrombin and synthetic thrombin receptor-activating peptides. J. Clin. Invest. 89:1992;1469-1477.
3. Cromack D. T., Porras-Reuys B. H., Wee S. S., Glenn K. C., Pardee, Carney D. H, Mustoe T. A. J. Surg. Res. 55:1992;117-122.
4. Stiernberg J., Redin W. R., Warner W. S., Carney D. H. The role of thrombin and thrombin receptor activating peptide (TRAP-508) in initiation of tissue repair. Thromb. Haemost. 70:1993;158-162.
5. Chen L. B., Buchanan J. M. Plasminogen-independent fibrinolysis by proteases produced by transformed chick embryo fibroblasts. Proc. Natl. Acad. Sci. USA. 72:1975;131-135.
6. Carney D. H., Glenn K. C., Cunningham D. D. Conditions which affect initiation of animal cell division by trypsin and thrombin. J. Cell. Physiol. 95:1978;13-22.
7. Pohjanpelto P. Proteases stimulate proliferation of human fibroblasts. J. Cell. Physiol. 91:1978;387-392.
8. Sower L. E., Froelich C. J., Allegretto N., Rose P. M., Hanna W. D., Klimpel G. R. Extracellular activities of human granzyme A: Monocyte activation by granzyme A versus α-thrombin. J. Immunol. 156:1996;2585-2590.
9. Naldini A., Carney D. H. Thrombin modulation of natural killer activity in human peripheral lymphocytes. Cell. Immunol. 172:1996;35-42.
10. Naldini A., Carney D. H., Bocci V., Klimpel K. D., Asuncion M., Soares L. E., Klimpel G. R. Thrombin enhances T cell proliferative responses and cytokine production. Cell. Immunol. 147:1993;367-377.
11. Bizios R., Lai L., Fenton J. W. II, Malik A. B. Thrombin-induced chemotaxis and aggregation of neutrophils. J. Cell. Physiol. 128:1986.
12. Bar-Shavit R., Kahn A., Fenton J. W. II, Wilner G. D. Chemotactic response of monocytes to thrombin. J. Cell. Biol. 96:1983.
13. Carney D. H., Cunningham D. D. Cell surface action of thrombin is sufficient to initiate division of chick cells. Cell. 14:1978;811-823.
14. Carney D. H., Cunningham D. D. Role of specific cell surface receptors in thrombin-stimulated cell division. Cell. 15:1978;1341-1349.
15. Glenn K. C., Carney D. H., Fenton J. W. II, Cunningham D. D. Thrombin active site regions required for fibroblast receptor binding and initiation of cell division. J. Biol. Chem. 255:1980;6609-6616.
16. Perdue J. F., Lubenskyi W., Kivity E., Sonder S., Fenton J. W. Protease mitogenic response of chick embryo fibroblasts and receptor binding/processing of human alpha-thrombin. J. Biol. Chem. 256:1981;2767-2776.
17. Carney D. H., Stiernberg J., Fenton J. W. Initiation of proliferative events by human alpha-thrombin requires both receptor binding and enzymatic activity. J. Cell. Biochem. 26:1984;181-195.
18. Carney D. H., Herbosa G. J., Stiernberg J., Bergmann J. S., Gordon E. A., Scott D., Fenton J. W. II. Double-signal hypothesis for thrombin initiation of cell proliferation. Semin. Thromb. Hemost. 12:1986;231-240.
19. He C-J., Peraldi M. N., Rebibou J. M., Meulders Q., Sraer J. D. Thrombin signal transduction mechanisms in human glomerular epithelial cells. J. Cell. Physiol. 150:1992;475-483.
20. Berk B. C., Taubmann M. B., Cragoe E. J. Jr., Fenton J. W. II, Griendling K. K. Thrombin signal transduction mechanisms in rat vascular smooth muscle cells: Calcium and protein kinase C-dependent and -independent pathways. J. Biol. Chem. 265:1990;17334-17340.
21. Gordon E. A., Carney D. H. Thrombin receptor occupancy initiates cell proliferation in the presence of phorbol myristic acetate. Biochem. Biophys. Res. Commun. 141:1986;650-656.
22. Frost G. H., Thompson W. C., Carney D. H. Monoclonal antibody to the thrombin receptor stimulates DNA synthesis in combination with gamma-thrombin or phorbol myristate acetate. J. Cell Biol. 105:1987;2551-2558.
23. Stiernberg J., LaBelle E. F., Carney D. H. Demonstration of a late amiloride-sensitive event as a necessary step in initiation of DNA synthesis by thrombin. J. Cell. Physiol. 117:1983;272-281.
24. Carney D. H., Scott D. L., Gordon E. A., LaBelle E. F. Phosphoinositides in mitogenesis: neomycin inhibits thrombin-stimulated phosphoinositide turnover and initiation of cell proliferation. Cell. 42:1985;479-488.
25. Paris S., Chambard J. C., Pouyssegur J. Coupling between phosphoinositide breakdown and early mitogenic events in fibroblasts: Studies with fluoroaluminate, vanadate, and pertussis toxin. J. Biol. Chem. 262:1987;1977-1983.
26. Raben D. M., Yasukda K. M., Cunningham D. D. Relationship of thrombin-stimulated arachidonic acid release and metabolism to mitogenesis and phosphatidylinositol synthesis. J. Cell. Physiol. 130:1987;466-473.
27. Rath H. M., Fee J. A., Rhee S. G., Silbert D. F. Characterization of phosphatidylinositol-specific phospholipase C defects associated with thrombin-induced mitogenesis. J. Biol. Chem. 265:1990;3080-3087.
28. Stiernberg J., Carney D. H., Fenton J. W. II, LaBelle E. F. Initiation of DNA synthesis by human thrombin: Relationships between receptor binding, enzymic activity, and stimulation of 86Rb+ influx. J. Cell. Physiol. 120:1984;289-295.
29. Carney D. H. Control of Animal Cell Proliferation. 1987;Academic Press, Orlando. p. 265-296.
30. Gordon E. A., Fenton J. W. II, Carney D. H. Thrombin-receptor occupancy initiates a transient increase in cAMP levels in mitogenically responsive hamster (NIL) fibroblasts. Ann. NY Acad. Sci. 485:1986;249-263.
31. Vu T-K. H., Hung D. T., Wheaton V. I., Coughlin S. R. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell. 64:1991;1057-1068.
32. +2. FEBS Lett. 288:1991;123-128.
33. Zhong C., Hayzer D. J., Corson M. A., Runge M. S. Molecular cloning of the rat vascular smooth muscle thrombin receptor: Evidence forin vitro. J. Biol. Chem. 267:1992;16975-16979.
34. Nystedt S., Emilsson K., Wahlestedt C., Sundelin J. Molecular cloning of a potential novel proteinase activated receptor. Proc. Natl. Acad. Sci. USA. 91:1994;9208-9212.
35. Ishihara H., Connolly A. J., Zeng D., Kahn M. L., Zheng Y. W., Timmons C., Tram T., Coughlin S. R. Protease-activated receptor 3 is a second thrombin receptor in humans. Nature. 386:1997;502-506.
36. Kahn M. L., Zheng Y. W., Huang W., Bigornia V., Zeng D. W., Moff S., Farese R. V., Tam C., Coughlin S. R. A dual thrombin receptor system for platelet activation. Nature. 394:1998;690-694.
37. Kahn M. L., Hammes S. R., Botka C., Coughlin S. R. Gene and locus structure and chromosomal localization of the protease-activated receptor gene family. J. Biol. Chem. 273:1998;23290-23296.
38. Vu T-K. H., Wheaton V. I., Hung D. T., Charo I., Coughlin S. R. Domains specifying thrombin-receptor interaction. Nature. 353:1991;674-677.
39. Baffy G., Yang L., Raj S., Manning D. R., Williamson J. R. G protein coupling to the thrombin receptor in chinese hamster lung fibroblasts. J. Biol. Chem. 269:1994;8483-8487.
40. Vouret-Craviari V., Van Obberghen-Schilling E., Rasmussen U. B., Pavirani A., Lecocq J-P., Pouyssegur J. Synthetic alpha-thrombin receptor peptides activate G protein-coupled signaling pathways but are unable to induce mitogenesis. J. Mol. Biol. Cell. 3:1992;95-102.
41. Connolly A. J., Suh D. Y., Hunt T. K., Coughlin S. R. Mice lacking the thrombin receptor, PAR1, have normal skin wound healing. Am. J. Pathol. 151:1997;1199-1204.
42. Kim D. W., Wang F., Ramakrishnan S., Scott D. L., Hensler T. M., Thompson W. C., Carney D. H. Mouse fibroblasts defective in thrombin mitogeness possess functional proteolytically activated receptor for thrombin: Requirement for a second signaling pathway. J. Cell. Physiol. 160:1994;573-584.
43. Sonne O. The specific binding of thrombin to human polymorphonuclear leucocytes. Scan. J. Clin. Lab. Invest. 48:1988.
44. Jenkins A. L., Howells G. L., Scott E., LeBonniec B. F., Curtis M. A., Stone S. R. The response to thrombin of human neutrophils: Evidence for two novel receptors. J. Cell Sci. 108:1995;3059-3066.
45. Kim, D. 1995, Ph.D. Dissertation.
46. Low D. A., Wiley H. S., Cunningham D. D. Role of cell surface thrombin binding sites in mitogenesis. Cancer Cells 3/Growth Factors and Transformation. 1985;Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
47. 125. J. Cell Biol. 95:1982;697-703.
48. Hoxie J. A., Ahuja M., Belmonte E., Pizarro S., Parton R., Brass L. F. Internalization and recycling of activated thrombin receptors. J. Biol. Chem. 268:1993;13756-13763.
49. Coughlin, S. R. 1998, Interactions between thrombin and thrombin receptor peptides studied with real-time BIA.
50. Hoehn G. T., Stokland T., Amin S., Ramirez M., Hawkins A. L., Griffin C. A., Small D., Civin C. I. Oncogene. 12:1996;903-913.
51. Chomczynski P., Mackey K. Substitution of chloroform with bromochloropropane in the single-step method of RNA isolation. Anal. Biochem. 225:1995;163-164.
52. Kuribayashi K., Hikata M., Hiraoka O., Miyamoto C., Furuichi Y. A rapid and efficient purification of poly(A)-mRNA by oligo(dT)30-latex. Nucleic Acids Res. Symp. Series. 19:1988;61-64.
53. McDonald J. A., Kelly D. G., Broekelmann T. J. Role of fibronectin in collagen deposition: Fab′ antibodies to the gelatin binding domain of fibronectin inhibits both fibronectin and collagen organization in fibroblast extracellular matrix. J. Cell Biol. 92:1982;485-492.
54. +2+2. DNA. 8:1989;675-682.
55. Voges D., Berendes R., Demange P., Benz J., Gottig P., Liemann S., Humber R., Burger A. Structure and function of the ion channel model system annexin V. Adv. Enzymol. Relat. Areas Mol. Biol. 71:1995;209-239.
56. Reutelingsperger C. P. M., Hornstra G., Hemker H. C. Isolation and partial purification of a novel anticoagulant from arteries of human umbiblical cord. Eur. J. Biochem. 151:1985;625-629.
57. Scandura, J. M. Ahmad, S. S. Walsh, P. N. 1996, A binding site expressed on the surface of activated human platelets is shared by factor X and prothrombin, Biochemistry, 35, 8890.
58. Rao L. V. M., Tait J., Hoang A. D. Binding of Annexin V to human ovarian carcinoma cell line (OC-2008): Contrasting effects on cell surface factor VIIa/tissue factor activity and prothrombinase activity. Thromb. Res. 67:1994;517-531.
59. Van Heerde W. L., Poort S., van 't Veer C., Reutelingsperger C. P. M., De Groot Ph. G. Binding of recombinant annexin V to endothelial cells: Effects of annexin V binding on endothelial-cell-medicated thrombin formation. Biochemical J. 302:1994;305-312.
60. Reutelingsperger C. P. M., Kop J. M. M., Hornstra G., Hemker H. C. Purification and characterization of a novel protein from bovine aorta that inhibits coagulation. Eur. J. Biochem. 173:1988;171-178.
61. Andree H. A. M., Stuart M. C. A., Hermens With., Reutelingsperger C. P. M., Hemker H. C., Frederik P. M., Willems G. M. Clustering of lipid-bound annexin V may explain its anticoagulant effect. J. Biol. Chem. 267:1992;17907-17912.
62. Almus F. E., Rao V. M., Rapaport S. I. Regulation of factor VIIa/tissue factor functional activity in an umbiblical vein model. Arterioscler. Thromb. 13:1993;105-111.
63. +2. Eur. J. Biochem. 185:1989;63-171.
64. Van Heerde W. L., Sakariassen K. S., Hemker H. C., Sixma J. J., Reutelingsperger C. P. M., De Groot Ph. G. Annexin V inhibits the procoagulant activity of matrices of TNF-stimulated endothelium under blood flow conditions. Arterioscler. Thromb. 14:1994;824-830.
65. Romisch J., Pacques E. Annexins: calcium-binding proteins of multi-functional importance? Med. Microbiol. Immunol. 180:1991;109-126.
66. Van Ryn-McKenna J., Merk H., Muller T. H., Buchanan M. R., Eisert W. G. The effects of heparin and annexin V on fibrin accretion after injury in the jugular veins of rabbits. Thromb. Haemost. 69:1993;227-230.
67. Sun J., Bird P., Salem H. H. Interaction of annexin V and platelets: Effects on platelet function and protein S binding. Thrombosis Res. 69:1993;289-296.
68. Parente L., Solito E., Giannessi P., Paggiari P., Sicari R., De Caterina R. Inhibition of eicosanoid formation and lipocortin induction by glucocorticoids in human cell lines and in patients with inflammatory lung disease. Pharmacol. Res. 26:1992;44-45.
69. Mollenhauer J., von der Mark K. Isolation and characterization of a collagen-binding glycoprotein from chondrocyte membranes. EMBO J. 2:1983;45-50.
70. Schlaepfer D. D., Mehlman T., Burgess W. H., Haigler H. T. Structural and functional characterization of endonexin II, a calcium- and phospholipid-binding protein. Proc. Natl. Acad. Sci. USA. 84:1987;6078-6082.
71. Giambanco I., Pula G., Bianchi R., Donato R. Interaction of two brain annexins, CaBP33 and CaBP37, with membrane-skeletal proteins. FEBS Lett. 267:1990;171-175.
72. Kirsch T., Pfaffle M. Selective binding of anchorin CII (AnnexinV) to type II and X collagen and to chondrocalcin (C-propeptide of type II collagen). FEBS Lett. 310:1992;143-147.
73. Wu L. N. Y., Genge B. R., Lloyd G. C., Wuthier R. E. Collagen-binding protein in collagenase-released matrix vesicles from cartilage. J. Biol. Chem. 266:1991;1195-1203.
74. Dubois T., Oudinet J. P., Mira J. P., Russo-Marie R. Annexins and protein kinase C. Biochim. Biophys. Acta. 1313:1996;290-294.
75. Schlaepfer D. D., Jones J., Haigler H. T. Inhibition of protein kinase C by annexin V. Biochemistry. 31:1992;1886-1891.
76. Raynal P., Hullin F., Ragab-Thomas J. M. F., Fauvel J., Chap H. Annexin V as a potential regulator of annexin 1 phosphorylation by protein kinase C. Biochem. J. 292:1993;759-765.
77. Rothhut B., Dubois T., Feliers D., Russo-Marie F., Oudinet J. P. Inhibitory effect of annexin V on protein kinase C activity in mesangial cell lysates. Eur. J. Biochem. 232:1995;865-872.
78. Shibata S., Sato H., Maki M. Calphobindings (placental annexins) inhibit protein kinase C. J. Biochem. 112:1992;552-556.
79. Dubois T., Oudinet J. P., Mira J. P., Russo-Marie R. Annexins and protein kinase C. Biochim. Biophys. Acta. 1313:1996;290-294.
80. Bhat N. R., Ahang P., Hogan E. L. Thrombin activates mitogen-activated protein kinase in primary astrocyte cultures. J. Cell. Physiol. 165:1995;417-424.
81. Wheeler-Jones C. P., Pearson J. D. Thrombin and histamine phosphorylate the 42 kDa mitogen-activated protein kinase in HUVEC. Biochem. Soc. Trans. 23:1995.
82. Nakashima S., Chatani Y., Nakamura M., Miyoshi N., Kohono M., Nozawa Y. Tyrosine phosphorylation and activation of mitogen-activated protein kinases by thrombin in human platelets: Possible involvement in late arachidonic acid release. Biochem. Biophys. Res. Commun. 198:1994;497-503.
83. Wilner G. D., Danitz M. P., Mudd S. M., Hsieh K-H., Fenton J. W. II. Selective immobilization of alpha-thrombin by surface-bound fibrin. J. Lab. Clin. Med. 97:1981;403-411.